SCHEMBL5536002

SCHEMBL5536002

O=C(NCCN1CCOCC1)c1c[nH]c(-c2n[nH]c3ncccc23)c1

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 3/20 0.51
WNT1 P04628 1/20 0.49
DYRK1A Q13627 1/20 0.49
PARP1 P09874 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
APP P05067 1/20 0.46
BCHE P06276 1/20 0.46
ACHE P22303 1/20 0.46
HPGD P15428 1/20 0.46
CD274 Q9NZQ7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22043996 0.82 RIPK1 (0.51) PARP1APPBCHEACHE
SCHEMBL14570476 0.80 NEK1 (0.50) APPBCHEACHEHPGD
SCHEMBL5541202 0.79 CAMKK2 (0.39) HPGDS
SCHEMBL5534980 0.79 MAPK3 (0.52) SMN1; SMN2
SCHEMBL5537482 0.78 ADORA2A (0.52) HPGDSDYRK1ASMN1; SMN2CYP1A2CYP2D6
SCHEMBL5538004 0.77 KMT2A (0.43) DYRK1ASMN1; SMN2HPGD
SCHEMBL22044070 0.77 MAPT (0.52) DYRK1ASMN1; SMN2CYP1A2CYP2D6CYP2C19
SCHEMBL22044137 0.77 NPC1 (0.48) PARP1SMN1; SMN2
SCHEMBL22044004 0.76 ADORA2A (0.43) CYP1A2CYP2D6CYP2C19HPGD
SCHEMBL22044077 0.76 KDM4E (0.51) SMN1; SMN2CYP1A2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7186716-B2 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors SUGEN, INC. (US) 2007-03-06 US disclosed
US-7186716-B2 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors SUGEN, INC. (US) 2007-03-06 US disclosed
US-7186716-B2 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors SUGEN, INC. (US) 2007-03-06 US disclosed